Clinical Trial: Stratification for F-L Therapy After LT
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Liver Transplantation
Study Type: OBSERVATIONAL
Official Title: Stratification for Efficacy of Adjuvant FOLFOX Plus Lenvatinib After Liver Transplantation for Hepatocellular Carcinoma in Recurrence Prevention
Brief Summary:
Objective: To stratify recipients who underwent adjuvant FOLFOX plus lenvatinib (F-L) therapy following liver transplantation (LT) for hepatocellular carcinoma and provide guidance for clinical adjuvant therapy.Methods: Liver recipients in the Shulan (Hangzhou) Hospital from January, 2017 to December, 2021, including 106 in the F-L therapy group and 229 in the non-adjuvant (N-A) therapy group were included in the analysis.A 1:1 propensity score matching (PSM) analysis was performed to minimize group…
Read more